Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[alpha-Glucosidase inhibitor].

H Ishida1

  • 1Third Department of Internal Medicine, Kyorin University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Hepatic involvement in Osler-Weber-Rendu disease: findings on pulsed and color Doppler sonography.

AJR. American journal of roentgenology·1995
Same author

Oligonucleotide-mediated modulation of mammalian gene expression.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·1995
Same author

Lethal shock is inducible by lipopolysaccharide but not by superantigen in mice with retrovirus-induced immunodeficiency syndrome.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Partial soleus muscle island flap transfer using minor pedicles from the posterior tibial vessels.

Plastic and reconstructive surgery·1995
Same author

Synthesis of sialyl Lewis X ganglioside analogues containing modified L-fucose residues.

Carbohydrate research·1995
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Voglibose, an alpha-glucosidase inhibitor, improved pancreatic islet function in diabetic rats. This oral anti-diabetic agent enhanced insulin secretion and content, potentially by protecting against glucose toxicity.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Metabolic Diseases

Context:

  • Non-insulin-dependent diabetes mellitus (NIDDM) is characterized by impaired pancreatic islet function.
  • Oral anti-diabetic agents offer alternative therapeutic strategies for managing hyperglycemia.
  • Alpha-glucosidase inhibitors represent a distinct class of hypoglycemic agents.

Purpose:

  • To evaluate the effects of voglibose on glycemic control and pancreatic islet function in a rat model of NIDDM.
  • To investigate the potential of voglibose to restore deteriorated islet function.

Summary:

  • Administration of voglibose for 8 weeks significantly improved glucose-induced insulin secretory capacity in Goto-Kakizaki (GK) rats.
  • Voglibose treatment nearly doubled the insulin content of pancreatic islets compared to untreated controls.

Related Experiment Videos

  • The study suggests voglibose may restore islet function in NIDDM by mitigating glucose toxicity.

    • Impact:

    • Voglibose demonstrates potential as a therapeutic agent for improving beta-cell function in NIDDM.
    • Findings contribute to understanding the mechanisms of alpha-glucosidase inhibitors in diabetes management.
    • This research supports the development of novel oral anti-diabetic drugs targeting islet dysfunction.